chr15-74183999-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022369.4(STRA6):​c.1167-10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 1,612,048 control chromosomes in the GnomAD database, including 23,597 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1928 hom., cov: 32)
Exomes 𝑓: 0.16 ( 21669 hom. )

Consequence

STRA6
NM_022369.4 intron

Scores

2
Splicing: ADA: 0.1402
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.342

Publications

14 publications found
Variant links:
Genes affected
STRA6 (HGNC:30650): (signaling receptor and transporter of retinol STRA6) The protein encoded by this gene is a membrane protein involved in the metabolism of retinol. The encoded protein acts as a receptor for retinol/retinol binding protein complexes. This protein removes the retinol from the complex and transports it across the cell membrane. Defects in this gene are a cause of syndromic microphthalmia type 9 (MCOPS9). Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
STRA6 Gene-Disease associations (from GenCC):
  • Matthew-Wood syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • microphthalmia, isolated, with coloboma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 15-74183999-G-C is Benign according to our data. Variant chr15-74183999-G-C is described in ClinVar as Benign. ClinVar VariationId is 261577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.337 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRA6NM_022369.4 linkc.1167-10C>G intron_variant Intron 13 of 18 ENST00000395105.9 NP_071764.3 Q9BX79-1B3KPB8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRA6ENST00000395105.9 linkc.1167-10C>G intron_variant Intron 13 of 18 1 NM_022369.4 ENSP00000378537.4 Q9BX79-1

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
22839
AN:
151968
Hom.:
1935
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0948
Gnomad AMI
AF:
0.109
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.351
Gnomad SAS
AF:
0.261
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.145
Gnomad OTH
AF:
0.147
GnomAD2 exomes
AF:
0.199
AC:
49696
AN:
249116
AF XY:
0.199
show subpopulations
Gnomad AFR exome
AF:
0.0871
Gnomad AMR exome
AF:
0.308
Gnomad ASJ exome
AF:
0.168
Gnomad EAS exome
AF:
0.346
Gnomad FIN exome
AF:
0.177
Gnomad NFE exome
AF:
0.149
Gnomad OTH exome
AF:
0.190
GnomAD4 exome
AF:
0.163
AC:
237389
AN:
1459964
Hom.:
21669
Cov.:
32
AF XY:
0.166
AC XY:
120575
AN XY:
726284
show subpopulations
African (AFR)
AF:
0.0857
AC:
2869
AN:
33478
American (AMR)
AF:
0.294
AC:
13151
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.174
AC:
4550
AN:
26136
East Asian (EAS)
AF:
0.356
AC:
14123
AN:
39688
South Asian (SAS)
AF:
0.265
AC:
22855
AN:
86250
European-Finnish (FIN)
AF:
0.168
AC:
8661
AN:
51626
Middle Eastern (MID)
AF:
0.183
AC:
1055
AN:
5768
European-Non Finnish (NFE)
AF:
0.143
AC:
159497
AN:
1111928
Other (OTH)
AF:
0.176
AC:
10628
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
11327
22654
33982
45309
56636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5904
11808
17712
23616
29520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.150
AC:
22823
AN:
152084
Hom.:
1928
Cov.:
32
AF XY:
0.154
AC XY:
11480
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.0945
AC:
3923
AN:
41508
American (AMR)
AF:
0.199
AC:
3034
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
591
AN:
3470
East Asian (EAS)
AF:
0.351
AC:
1806
AN:
5150
South Asian (SAS)
AF:
0.260
AC:
1251
AN:
4814
European-Finnish (FIN)
AF:
0.182
AC:
1928
AN:
10588
Middle Eastern (MID)
AF:
0.188
AC:
55
AN:
292
European-Non Finnish (NFE)
AF:
0.145
AC:
9831
AN:
67956
Other (OTH)
AF:
0.145
AC:
305
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
997
1995
2992
3990
4987
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.105
Hom.:
217
Bravo
AF:
0.150
Asia WGS
AF:
0.317
AC:
1100
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Matthew-Wood syndrome Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
3.4
DANN
Benign
0.73
PhyloP100
0.34
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.14
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.31
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.31
Position offset: -10

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2277608; hg19: chr15-74476340; COSMIC: COSV60585074; COSMIC: COSV60585074; API